Alan Tackett
Concepts (584)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histones | 34 | 2025 | 297 | 5.630 |
Why?
| Melanoma | 12 | 2024 | 280 | 4.030 |
Why?
| Proteomics | 21 | 2023 | 314 | 3.690 |
Why?
| Saccharomyces cerevisiae Proteins | 21 | 2019 | 138 | 3.600 |
Why?
| Saccharomyces cerevisiae | 18 | 2019 | 175 | 2.880 |
Why?
| Chromatin | 18 | 2025 | 137 | 2.730 |
Why?
| Mass Spectrometry | 23 | 2021 | 285 | 2.660 |
Why?
| Protein Processing, Post-Translational | 14 | 2020 | 156 | 2.170 |
Why?
| Proteome | 12 | 2024 | 169 | 2.060 |
Why?
| Chromosomal Proteins, Non-Histone | 7 | 2021 | 36 | 1.500 |
Why?
| Protein Interaction Mapping | 4 | 2020 | 37 | 1.120 |
Why?
| Nuclear Proteins | 7 | 2017 | 238 | 0.960 |
Why?
| Skin Neoplasms | 4 | 2020 | 491 | 0.920 |
Why?
| Histone Demethylases | 4 | 2014 | 17 | 0.900 |
Why?
| Immunotherapy | 4 | 2021 | 235 | 0.890 |
Why?
| Animals | 51 | 2025 | 13124 | 0.880 |
Why?
| Lysine | 6 | 2023 | 84 | 0.870 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2023 | 213 | 0.870 |
Why?
| Transcription Factors | 13 | 2025 | 565 | 0.860 |
Why?
| Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 76 | 0.850 |
Why?
| Mice | 33 | 2023 | 5687 | 0.830 |
Why?
| Melanoma, Experimental | 2 | 2021 | 40 | 0.790 |
Why?
| Bacterial Proteins | 7 | 2020 | 367 | 0.770 |
Why?
| Drug Resistance, Neoplasm | 3 | 2020 | 316 | 0.760 |
Why?
| CTLA-4 Antigen | 2 | 2021 | 23 | 0.750 |
Why?
| Cadherins | 2 | 2019 | 63 | 0.740 |
Why?
| Histone Code | 2 | 2020 | 30 | 0.720 |
Why?
| Gene Expression Regulation, Neoplastic | 10 | 2025 | 833 | 0.720 |
Why?
| Neoplasms | 7 | 2021 | 1251 | 0.710 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 59 | 0.690 |
Why?
| Genetic Loci | 3 | 2015 | 45 | 0.680 |
Why?
| DNA-Binding Proteins | 9 | 2021 | 418 | 0.680 |
Why?
| Epigenesis, Genetic | 9 | 2023 | 372 | 0.680 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 110 | 0.680 |
Why?
| Gene Expression Regulation, Fungal | 5 | 2019 | 52 | 0.670 |
Why?
| Immunohistochemistry | 3 | 2020 | 957 | 0.650 |
Why?
| Histone Acetyltransferases | 5 | 2014 | 21 | 0.640 |
Why?
| Integrin alpha Chains | 1 | 2019 | 9 | 0.640 |
Why?
| Arsenic | 1 | 2019 | 22 | 0.630 |
Why?
| Cell Cycle Checkpoints | 1 | 2019 | 29 | 0.630 |
Why?
| Protein Binding | 21 | 2021 | 654 | 0.620 |
Why?
| Cell Line, Tumor | 13 | 2023 | 1398 | 0.610 |
Why?
| Gene Silencing | 5 | 2023 | 115 | 0.600 |
Why?
| Humans | 59 | 2025 | 50503 | 0.590 |
Why?
| Apoptosis | 11 | 2023 | 1097 | 0.590 |
Why?
| Staphylococcus aureus | 5 | 2020 | 321 | 0.580 |
Why?
| Antigens, CD | 1 | 2019 | 222 | 0.580 |
Why?
| Tumor Escape | 1 | 2017 | 17 | 0.560 |
Why?
| Immunologic Surveillance | 1 | 2017 | 11 | 0.560 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2017 | 39 | 0.550 |
Why?
| Blood Proteins | 1 | 2017 | 84 | 0.540 |
Why?
| Whole-Body Irradiation | 1 | 2017 | 132 | 0.530 |
Why?
| Chromatin Immunoprecipitation | 4 | 2012 | 48 | 0.520 |
Why?
| Up-Regulation | 3 | 2018 | 446 | 0.510 |
Why?
| Tumor Microenvironment | 4 | 2022 | 222 | 0.500 |
Why?
| Chromatography, Affinity | 2 | 2012 | 39 | 0.500 |
Why?
| Nuclear Pore Complex Proteins | 3 | 2025 | 10 | 0.490 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2015 | 23 | 0.490 |
Why?
| Space Flight | 3 | 2020 | 31 | 0.490 |
Why?
| DNA-Activated Protein Kinase | 1 | 2015 | 22 | 0.480 |
Why?
| Chemical Fractionation | 1 | 2015 | 16 | 0.480 |
Why?
| Proto-Oncogene Proteins c-ret | 1 | 2015 | 33 | 0.480 |
Why?
| Antineoplastic Agents | 6 | 2023 | 1172 | 0.470 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2012 | 62 | 0.470 |
Why?
| DNA | 6 | 2023 | 535 | 0.460 |
Why?
| Methylation | 10 | 2023 | 118 | 0.460 |
Why?
| Repressor Proteins | 4 | 2019 | 148 | 0.460 |
Why?
| Membrane Proteins | 2 | 2020 | 332 | 0.460 |
Why?
| Cell Cycle Proteins | 6 | 2021 | 161 | 0.450 |
Why?
| Thyroid Neoplasms | 1 | 2015 | 112 | 0.440 |
Why?
| DNA Helicases | 6 | 2012 | 146 | 0.430 |
Why?
| Virulence Factors | 4 | 2020 | 78 | 0.420 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 135 | 0.420 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 462 | 0.420 |
Why?
| Peptide Hydrolases | 3 | 2020 | 61 | 0.420 |
Why?
| Lung Neoplasms | 1 | 2019 | 601 | 0.410 |
Why?
| Pancreatic Neoplasms | 1 | 2015 | 206 | 0.410 |
Why?
| Amino Acid Sequence | 11 | 2014 | 574 | 0.400 |
Why?
| Nevus, Pigmented | 2 | 2012 | 34 | 0.390 |
Why?
| T-Lymphocytes | 3 | 2020 | 325 | 0.390 |
Why?
| Radiation, Ionizing | 3 | 2017 | 100 | 0.380 |
Why?
| Epistasis, Genetic | 2 | 2009 | 29 | 0.380 |
Why?
| Molecular Sequence Data | 10 | 2014 | 778 | 0.380 |
Why?
| Viral Nonstructural Proteins | 3 | 2008 | 56 | 0.370 |
Why?
| Promoter Regions, Genetic | 5 | 2023 | 465 | 0.370 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2021 | 31 | 0.370 |
Why?
| DNA Methylation | 5 | 2023 | 550 | 0.360 |
Why?
| Cell Proliferation | 7 | 2023 | 985 | 0.350 |
Why?
| Oligonucleotides | 3 | 2008 | 80 | 0.350 |
Why?
| Galactokinase | 3 | 2015 | 7 | 0.330 |
Why?
| Exosomes | 2 | 2021 | 48 | 0.330 |
Why?
| Chromosome Positioning | 1 | 2009 | 1 | 0.330 |
Why?
| Oncogene Proteins, Fusion | 3 | 2025 | 57 | 0.330 |
Why?
| Proteins | 2 | 2018 | 339 | 0.320 |
Why?
| Trans-Activators | 2 | 2020 | 134 | 0.320 |
Why?
| Protein Kinase Inhibitors | 2 | 2021 | 204 | 0.320 |
Why?
| Multiple Myeloma | 3 | 2023 | 2998 | 0.310 |
Why?
| Colonic Neoplasms | 2 | 2021 | 158 | 0.310 |
Why?
| Viral Proteins | 4 | 2009 | 153 | 0.300 |
Why?
| Long Interspersed Nucleotide Elements | 3 | 2017 | 37 | 0.300 |
Why?
| DNA Replication | 2 | 2010 | 156 | 0.300 |
Why?
| Formaldehyde | 3 | 2015 | 49 | 0.290 |
Why?
| Chromatin Assembly and Disassembly | 4 | 2021 | 23 | 0.290 |
Why?
| Brain Neoplasms | 2 | 2022 | 291 | 0.290 |
Why?
| DNA, Single-Stranded | 3 | 2005 | 89 | 0.290 |
Why?
| Neoplasm Proteins | 3 | 2016 | 320 | 0.280 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 3 | 2016 | 17 | 0.270 |
Why?
| Neoplasm Metastasis | 3 | 2016 | 232 | 0.270 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 174 | 0.270 |
Why?
| Virulence | 5 | 2020 | 168 | 0.270 |
Why?
| Homologous Recombination | 2 | 2018 | 41 | 0.270 |
Why?
| Osteomyelitis | 2 | 2019 | 128 | 0.270 |
Why?
| HEK293 Cells | 7 | 2021 | 213 | 0.260 |
Why?
| Protein Structure, Tertiary | 8 | 2014 | 245 | 0.260 |
Why?
| Retroelements | 2 | 2023 | 12 | 0.260 |
Why?
| Acetylation | 8 | 2021 | 94 | 0.260 |
Why?
| Xenopus Proteins | 2 | 2019 | 29 | 0.250 |
Why?
| Homeodomain Proteins | 3 | 2025 | 79 | 0.250 |
Why?
| Disease Progression | 5 | 2023 | 829 | 0.250 |
Why?
| Transcription, Genetic | 4 | 2009 | 361 | 0.250 |
Why?
| Hepacivirus | 4 | 2008 | 105 | 0.240 |
Why?
| Nerve Tissue Proteins | 3 | 2019 | 194 | 0.240 |
Why?
| Co-Repressor Proteins | 2 | 2023 | 17 | 0.240 |
Why?
| Phosphorylation | 6 | 2017 | 525 | 0.240 |
Why?
| Mice, Inbred C57BL | 9 | 2021 | 1808 | 0.240 |
Why?
| Disease Models, Animal | 5 | 2021 | 1436 | 0.230 |
Why?
| Gene Expression Regulation, Bacterial | 5 | 2020 | 188 | 0.230 |
Why?
| Glycine | 1 | 2025 | 78 | 0.230 |
Why?
| Signal Transduction | 5 | 2020 | 1624 | 0.230 |
Why?
| Proteolysis | 2 | 2022 | 96 | 0.230 |
Why?
| Phenylalanine | 1 | 2025 | 134 | 0.230 |
Why?
| Endothelial Cells | 3 | 2021 | 258 | 0.230 |
Why?
| Staphylococcal Infections | 4 | 2020 | 267 | 0.230 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2022 | 95 | 0.220 |
Why?
| Antigen Presentation | 1 | 2023 | 25 | 0.220 |
Why?
| Endogenous Retroviruses | 1 | 2023 | 7 | 0.220 |
Why?
| Tumor Cells, Cultured | 3 | 2021 | 457 | 0.220 |
Why?
| Bacteriophage T4 | 4 | 2009 | 30 | 0.220 |
Why?
| Polyporaceae | 1 | 2023 | 2 | 0.210 |
Why?
| Transcriptional Activation | 5 | 2025 | 119 | 0.210 |
Why?
| Workflow | 2 | 2020 | 50 | 0.210 |
Why?
| Methionine | 1 | 2024 | 134 | 0.210 |
Why?
| Ikaros Transcription Factor | 1 | 2022 | 5 | 0.200 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 140 | 0.200 |
Why?
| Weightlessness | 2 | 2020 | 12 | 0.200 |
Why?
| High-Throughput Screening Assays | 2 | 2013 | 35 | 0.200 |
Why?
| Peptide Nucleic Acids | 1 | 2002 | 18 | 0.200 |
Why?
| Cytochrome P-450 CYP2E1 | 2 | 2017 | 111 | 0.200 |
Why?
| DNA Breaks, Double-Stranded | 3 | 2017 | 65 | 0.190 |
Why?
| Breast Neoplasms | 3 | 2016 | 1201 | 0.190 |
Why?
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 112 | 0.190 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2022 | 41 | 0.190 |
Why?
| Cell Line | 7 | 2023 | 988 | 0.190 |
Why?
| Phosphofructokinase-1, Type C | 1 | 2021 | 3 | 0.190 |
Why?
| YY1 Transcription Factor | 1 | 2021 | 6 | 0.190 |
Why?
| Ribonucleoproteins | 2 | 2019 | 19 | 0.190 |
Why?
| Polycomb-Group Proteins | 1 | 2021 | 7 | 0.190 |
Why?
| Fungal Proteins | 3 | 2018 | 123 | 0.190 |
Why?
| Spectrum Analysis, Raman | 1 | 2021 | 55 | 0.190 |
Why?
| Aging | 2 | 2016 | 693 | 0.180 |
Why?
| Gene Expression Profiling | 3 | 2023 | 1025 | 0.180 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2021 | 18 | 0.180 |
Why?
| Mutation | 8 | 2020 | 1280 | 0.180 |
Why?
| Glioblastoma | 1 | 2022 | 94 | 0.180 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 80 | 0.180 |
Why?
| Open Reading Frames | 4 | 2014 | 47 | 0.180 |
Why?
| Blood-Brain Barrier | 1 | 2020 | 47 | 0.170 |
Why?
| Histone-Lysine N-Methyltransferase | 2 | 2014 | 54 | 0.170 |
Why?
| Cluster Analysis | 2 | 2019 | 219 | 0.170 |
Why?
| Time Factors | 5 | 2017 | 2935 | 0.170 |
Why?
| Cells, Cultured | 5 | 2018 | 1571 | 0.170 |
Why?
| Dose-Response Relationship, Radiation | 2 | 2017 | 183 | 0.170 |
Why?
| Neovascularization, Pathologic | 1 | 2021 | 155 | 0.170 |
Why?
| Nucleosomes | 4 | 2013 | 11 | 0.170 |
Why?
| Translocation, Genetic | 1 | 2021 | 240 | 0.170 |
Why?
| Hematopoietic Stem Cells | 2 | 2021 | 197 | 0.170 |
Why?
| Models, Molecular | 5 | 2013 | 334 | 0.160 |
Why?
| Adaptation, Ocular | 1 | 2019 | 2 | 0.160 |
Why?
| Cell Cycle | 4 | 2019 | 226 | 0.160 |
Why?
| Blood-Retinal Barrier | 1 | 2019 | 5 | 0.160 |
Why?
| Malpractice | 1 | 2019 | 16 | 0.160 |
Why?
| Poly(A)-Binding Proteins | 1 | 2019 | 5 | 0.160 |
Why?
| Male | 17 | 2021 | 25907 | 0.160 |
Why?
| Phosphoproteins | 1 | 2020 | 115 | 0.160 |
Why?
| Genome, Fungal | 3 | 2010 | 39 | 0.160 |
Why?
| Arsenate Reductases | 1 | 2019 | 3 | 0.160 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2019 | 46 | 0.160 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 10 | 0.160 |
Why?
| Chromatography, Liquid | 3 | 2020 | 231 | 0.160 |
Why?
| RNA-Binding Proteins | 3 | 2019 | 118 | 0.160 |
Why?
| Protein Kinases | 1 | 2019 | 71 | 0.160 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2021 | 181 | 0.160 |
Why?
| Ruminococcus | 1 | 2019 | 7 | 0.160 |
Why?
| Starch | 1 | 2019 | 12 | 0.160 |
Why?
| Diagnostic Errors | 1 | 2019 | 66 | 0.160 |
Why?
| Muscles | 2 | 2016 | 104 | 0.160 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 98 | 0.160 |
Why?
| Membrane Transport Proteins | 1 | 2019 | 47 | 0.160 |
Why?
| Cecum | 1 | 2019 | 60 | 0.160 |
Why?
| Mutation Rate | 1 | 2018 | 35 | 0.160 |
Why?
| Gravity, Altered | 1 | 2018 | 2 | 0.160 |
Why?
| Oxidative Stress | 2 | 2020 | 772 | 0.160 |
Why?
| Myocytes, Cardiac | 1 | 2019 | 123 | 0.150 |
Why?
| Lipopolysaccharides | 1 | 2019 | 197 | 0.150 |
Why?
| Adenosine | 1 | 2018 | 71 | 0.150 |
Why?
| Chromans | 1 | 2018 | 35 | 0.150 |
Why?
| Computational Biology | 1 | 2020 | 215 | 0.150 |
Why?
| Transcriptional Elongation Factors | 2 | 2009 | 17 | 0.150 |
Why?
| Retina | 1 | 2018 | 63 | 0.150 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 125 | 0.150 |
Why?
| Genomics | 2 | 2013 | 279 | 0.150 |
Why?
| Models, Chemical | 3 | 2010 | 64 | 0.150 |
Why?
| Software | 1 | 2020 | 276 | 0.150 |
Why?
| Vitamin E | 1 | 2018 | 78 | 0.140 |
Why?
| Kinetics | 5 | 2010 | 623 | 0.140 |
Why?
| Protein Biosynthesis | 3 | 2019 | 232 | 0.140 |
Why?
| Mentors | 1 | 2018 | 55 | 0.140 |
Why?
| Spleen | 1 | 2018 | 169 | 0.140 |
Why?
| Scavenger Receptors, Class E | 1 | 2019 | 203 | 0.140 |
Why?
| Gene Expression Regulation | 4 | 2019 | 955 | 0.140 |
Why?
| Interleukin-2 | 1 | 2017 | 71 | 0.140 |
Why?
| Cell Differentiation | 5 | 2021 | 640 | 0.140 |
Why?
| Radiation Injuries | 1 | 2018 | 112 | 0.140 |
Why?
| Program Development | 1 | 2018 | 162 | 0.140 |
Why?
| Immunomodulation | 1 | 2017 | 36 | 0.140 |
Why?
| Muscle Development | 2 | 2014 | 22 | 0.140 |
Why?
| Macaca mulatta | 1 | 2017 | 97 | 0.140 |
Why?
| Mitochondria | 1 | 2020 | 399 | 0.140 |
Why?
| Myocardial Infarction | 1 | 2021 | 403 | 0.140 |
Why?
| Gamma Rays | 1 | 2017 | 47 | 0.140 |
Why?
| Sequence Homology, Amino Acid | 2 | 2015 | 144 | 0.140 |
Why?
| Universities | 1 | 2018 | 171 | 0.140 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2017 | 51 | 0.140 |
Why?
| Tetrahymena thermophila | 2 | 2014 | 3 | 0.140 |
Why?
| Dose-Response Relationship, Drug | 4 | 2020 | 1372 | 0.140 |
Why?
| Mitochondrial Proteins | 2 | 2018 | 88 | 0.130 |
Why?
| Lymphocyte Activation | 1 | 2017 | 164 | 0.130 |
Why?
| 3' Untranslated Regions | 1 | 2016 | 52 | 0.130 |
Why?
| Myogenin | 2 | 2014 | 4 | 0.130 |
Why?
| Mitochondria, Liver | 1 | 2017 | 69 | 0.130 |
Why?
| Alcohol Drinking | 1 | 2018 | 227 | 0.130 |
Why?
| Biofilms | 4 | 2020 | 182 | 0.130 |
Why?
| Oocytes | 2 | 2019 | 75 | 0.130 |
Why?
| Butadienes | 1 | 2017 | 49 | 0.130 |
Why?
| Mice, Inbred BALB C | 3 | 2021 | 296 | 0.130 |
Why?
| Calcineurin | 1 | 2017 | 73 | 0.130 |
Why?
| Protozoan Proteins | 2 | 2014 | 32 | 0.130 |
Why?
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.130 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2016 | 9 | 0.130 |
Why?
| Peptide Fragments | 3 | 2013 | 209 | 0.130 |
Why?
| Adenine | 1 | 2016 | 31 | 0.130 |
Why?
| Cell Movement | 1 | 2017 | 247 | 0.130 |
Why?
| Autoantigens | 1 | 2016 | 48 | 0.130 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 44 | 0.130 |
Why?
| Epigenomics | 1 | 2016 | 68 | 0.130 |
Why?
| Ethanol | 1 | 2018 | 336 | 0.130 |
Why?
| Caenorhabditis elegans | 1 | 2016 | 134 | 0.130 |
Why?
| Tumor Burden | 1 | 2016 | 130 | 0.130 |
Why?
| Kidney | 1 | 2020 | 696 | 0.130 |
Why?
| Antigens, Viral | 1 | 2015 | 42 | 0.130 |
Why?
| Carcinogens | 1 | 2017 | 196 | 0.130 |
Why?
| Rhadinovirus | 1 | 2015 | 21 | 0.120 |
Why?
| Macromolecular Substances | 2 | 2005 | 34 | 0.120 |
Why?
| Proto-Oncogene Proteins c-myb | 1 | 2015 | 8 | 0.120 |
Why?
| Chromosomes, Fungal | 2 | 2012 | 13 | 0.120 |
Why?
| Endoplasmic Reticulum | 1 | 2016 | 108 | 0.120 |
Why?
| Cell Survival | 5 | 2019 | 589 | 0.120 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 179 | 0.120 |
Why?
| Mitosis | 2 | 2013 | 88 | 0.120 |
Why?
| Curriculum | 1 | 2018 | 400 | 0.120 |
Why?
| Collagen | 1 | 2016 | 204 | 0.120 |
Why?
| Heterochromatin | 1 | 2014 | 4 | 0.120 |
Why?
| Carcinoma, Merkel Cell | 1 | 2015 | 40 | 0.120 |
Why?
| Biomedical Research | 1 | 2018 | 244 | 0.120 |
Why?
| Liver | 2 | 2018 | 1132 | 0.120 |
Why?
| Hippocampus | 1 | 2016 | 222 | 0.120 |
Why?
| Virus Replication | 1 | 2015 | 139 | 0.120 |
Why?
| Phenelzine | 1 | 2014 | 4 | 0.110 |
Why?
| Cell Culture Techniques | 1 | 2015 | 96 | 0.110 |
Why?
| Host-Pathogen Interactions | 1 | 2015 | 135 | 0.110 |
Why?
| T-Box Domain Proteins | 1 | 2014 | 13 | 0.110 |
Why?
| Prognosis | 1 | 2019 | 1978 | 0.110 |
Why?
| Rhabdomyosarcoma | 1 | 2014 | 10 | 0.110 |
Why?
| G-Quadruplexes | 1 | 2015 | 75 | 0.110 |
Why?
| Threonine | 1 | 2013 | 15 | 0.110 |
Why?
| Heart | 1 | 2016 | 341 | 0.110 |
Why?
| Models, Biological | 3 | 2012 | 716 | 0.110 |
Why?
| Enhancer Elements, Genetic | 3 | 2021 | 58 | 0.110 |
Why?
| Female | 13 | 2021 | 27081 | 0.110 |
Why?
| Sarcoma | 1 | 2014 | 65 | 0.100 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2013 | 22 | 0.100 |
Why?
| Macaca | 1 | 2012 | 7 | 0.100 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2012 | 9 | 0.100 |
Why?
| Treatment Outcome | 2 | 2020 | 5283 | 0.100 |
Why?
| Alzheimer Disease | 1 | 2016 | 316 | 0.100 |
Why?
| Sirtuin 1 | 1 | 2012 | 28 | 0.100 |
Why?
| Indoles | 1 | 2015 | 278 | 0.100 |
Why?
| DNA Repair Enzymes | 1 | 2012 | 43 | 0.100 |
Why?
| Brain | 1 | 2020 | 1319 | 0.100 |
Why?
| Proto-Oncogene Proteins c-mos | 1 | 2012 | 7 | 0.100 |
Why?
| Enzyme Inhibitors | 1 | 2014 | 377 | 0.100 |
Why?
| gp100 Melanoma Antigen | 1 | 2011 | 8 | 0.100 |
Why?
| Fixatives | 1 | 2011 | 12 | 0.100 |
Why?
| Tissue Fixation | 1 | 2011 | 34 | 0.090 |
Why?
| Escherichia coli | 2 | 2014 | 190 | 0.090 |
Why?
| Paraffin Embedding | 1 | 2011 | 51 | 0.090 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 117 | 0.090 |
Why?
| Mice, Knockout | 3 | 2021 | 844 | 0.090 |
Why?
| Cell Transformation, Neoplastic | 2 | 2023 | 181 | 0.090 |
Why?
| Bone Neoplasms | 1 | 2013 | 179 | 0.090 |
Why?
| Hypertension | 1 | 2016 | 544 | 0.090 |
Why?
| Neurons | 1 | 2014 | 452 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 461 | 0.090 |
Why?
| Diet, High-Fat | 1 | 2012 | 214 | 0.090 |
Why?
| Wnt Signaling Pathway | 2 | 2023 | 86 | 0.090 |
Why?
| Hexosyltransferases | 1 | 2010 | 1 | 0.090 |
Why?
| Maltose | 1 | 2010 | 3 | 0.090 |
Why?
| Mycobacterium smegmatis | 1 | 2010 | 3 | 0.090 |
Why?
| Substrate Specificity | 4 | 2015 | 192 | 0.090 |
Why?
| Sugar Phosphates | 1 | 2010 | 3 | 0.090 |
Why?
| Trehalose | 1 | 2010 | 6 | 0.090 |
Why?
| Glycogen | 1 | 2010 | 42 | 0.080 |
Why?
| Movement | 1 | 2010 | 82 | 0.080 |
Why?
| Chromatography | 2 | 2008 | 12 | 0.080 |
Why?
| Adenosine Triphosphatases | 3 | 2008 | 87 | 0.080 |
Why?
| Peptides | 2 | 2013 | 221 | 0.080 |
Why?
| RNA, Messenger | 3 | 2019 | 1089 | 0.080 |
Why?
| Protein Stability | 2 | 2020 | 43 | 0.080 |
Why?
| DNA Repair | 3 | 2017 | 188 | 0.080 |
Why?
| Molecular Chaperones | 1 | 2009 | 61 | 0.080 |
Why?
| Peptide Mapping | 1 | 2008 | 21 | 0.080 |
Why?
| Microtubules | 1 | 2008 | 36 | 0.080 |
Why?
| Histone Deacetylases | 2 | 2023 | 50 | 0.080 |
Why?
| Sequence Alignment | 3 | 2014 | 119 | 0.080 |
Why?
| Recombinant Fusion Proteins | 1 | 2009 | 179 | 0.080 |
Why?
| bcl-2-Associated X Protein | 1 | 2008 | 57 | 0.080 |
Why?
| RNA Helicases | 1 | 2008 | 29 | 0.080 |
Why?
| Mice, SCID | 2 | 2021 | 178 | 0.080 |
Why?
| bcl-X Protein | 1 | 2008 | 53 | 0.080 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2008 | 14 | 0.070 |
Why?
| HeLa Cells | 3 | 2021 | 247 | 0.070 |
Why?
| DNA Primers | 1 | 2008 | 206 | 0.070 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2020 | 212 | 0.070 |
Why?
| Recombinant Proteins | 3 | 2018 | 476 | 0.070 |
Why?
| Rats | 3 | 2019 | 3292 | 0.070 |
Why?
| Tandem Mass Spectrometry | 2 | 2018 | 238 | 0.070 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 19 | 0.070 |
Why?
| Binding Sites | 3 | 2014 | 362 | 0.070 |
Why?
| MCF-7 Cells | 2 | 2016 | 62 | 0.070 |
Why?
| Gene Knockdown Techniques | 2 | 2016 | 105 | 0.070 |
Why?
| Meiosis | 2 | 2018 | 64 | 0.070 |
Why?
| E1A-Associated p300 Protein | 1 | 2006 | 9 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 2 | 2021 | 95 | 0.070 |
Why?
| Reactive Oxygen Species | 2 | 2018 | 409 | 0.070 |
Why?
| Nuclear Pore | 1 | 2005 | 1 | 0.060 |
Why?
| Xenopus laevis | 2 | 2019 | 39 | 0.060 |
Why?
| RNA Interference | 2 | 2016 | 178 | 0.060 |
Why?
| Staphylococcal Protein A | 1 | 2005 | 7 | 0.060 |
Why?
| Trypsin | 1 | 2005 | 12 | 0.060 |
Why?
| DNA Polymerase II | 1 | 2005 | 9 | 0.060 |
Why?
| Osteoblasts | 2 | 2020 | 462 | 0.060 |
Why?
| Phenotype | 2 | 2020 | 739 | 0.060 |
Why?
| Osteoclasts | 2 | 2020 | 427 | 0.060 |
Why?
| Acetyltransferases | 1 | 2005 | 19 | 0.060 |
Why?
| Proto-Oncogenes | 1 | 2005 | 27 | 0.060 |
Why?
| Flow Cytometry | 1 | 2008 | 474 | 0.060 |
Why?
| Protein Denaturation | 1 | 2005 | 15 | 0.060 |
Why?
| Spectrometry, Fluorescence | 1 | 2005 | 46 | 0.060 |
Why?
| Amino Acid Motifs | 2 | 2020 | 55 | 0.060 |
Why?
| RNA, Viral | 1 | 2005 | 107 | 0.060 |
Why?
| Mammals | 2 | 2016 | 50 | 0.060 |
Why?
| Microscopy, Fluorescence | 1 | 2005 | 158 | 0.060 |
Why?
| Mutation, Missense | 2 | 2018 | 103 | 0.060 |
Why?
| Gene Deletion | 2 | 2015 | 261 | 0.060 |
Why?
| RNA | 1 | 2005 | 163 | 0.060 |
Why?
| Terminal Repeat Sequences | 1 | 2023 | 10 | 0.060 |
Why?
| S-Adenosylmethionine | 1 | 2024 | 62 | 0.060 |
Why?
| Transfection | 2 | 2016 | 356 | 0.060 |
Why?
| Major Histocompatibility Complex | 1 | 2023 | 12 | 0.060 |
Why?
| Interferons | 1 | 2023 | 38 | 0.050 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 405 | 0.050 |
Why?
| MyoD Protein | 2 | 2014 | 8 | 0.050 |
Why?
| Histocompatibility Antigens Class I | 1 | 2023 | 46 | 0.050 |
Why?
| Evolution, Molecular | 2 | 2016 | 95 | 0.050 |
Why?
| Tamoxifen | 1 | 2023 | 60 | 0.050 |
Why?
| HLA Antigens | 1 | 2023 | 52 | 0.050 |
Why?
| Genome | 1 | 2023 | 65 | 0.050 |
Why?
| Mycelium | 1 | 2023 | 2 | 0.050 |
Why?
| Homocysteine | 1 | 2024 | 127 | 0.050 |
Why?
| Trametes | 1 | 2023 | 3 | 0.050 |
Why?
| Integrin beta Chains | 1 | 2023 | 13 | 0.050 |
Why?
| Integrins | 1 | 2023 | 30 | 0.050 |
Why?
| Young Adult | 3 | 2018 | 4102 | 0.050 |
Why?
| Active Transport, Cell Nucleus | 2 | 2017 | 34 | 0.050 |
Why?
| Cytogenetic Analysis | 1 | 2023 | 74 | 0.050 |
Why?
| Rats, Sprague-Dawley | 2 | 2019 | 1585 | 0.050 |
Why?
| Antigens, Neoplasm | 1 | 2023 | 148 | 0.050 |
Why?
| Monensin | 1 | 2022 | 9 | 0.050 |
Why?
| Animals, Newborn | 1 | 2023 | 363 | 0.050 |
Why?
| Adult | 4 | 2022 | 13577 | 0.050 |
Why?
| Fetus | 2 | 2014 | 183 | 0.050 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 2002 | 9 | 0.050 |
Why?
| Simian virus 40 | 1 | 2002 | 14 | 0.050 |
Why?
| Fluorescence Polarization | 1 | 2002 | 18 | 0.050 |
Why?
| Streptavidin | 1 | 2002 | 16 | 0.050 |
Why?
| Organoids | 1 | 2022 | 36 | 0.050 |
Why?
| DNA, Viral | 1 | 2002 | 136 | 0.050 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 72 | 0.050 |
Why?
| Blotting, Western | 2 | 2014 | 578 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 198 | 0.050 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2021 | 29 | 0.050 |
Why?
| Cell Line, Transformed | 1 | 2021 | 73 | 0.050 |
Why?
| Glycolysis | 1 | 2021 | 69 | 0.040 |
Why?
| GTP Phosphohydrolases | 1 | 2020 | 28 | 0.040 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 39 | 0.040 |
Why?
| Immunity, Cellular | 1 | 2020 | 63 | 0.040 |
Why?
| Middle Aged | 4 | 2020 | 12611 | 0.040 |
Why?
| Genome, Human | 1 | 2021 | 109 | 0.040 |
Why?
| Bacterial Toxins | 1 | 2020 | 51 | 0.040 |
Why?
| Metalloendopeptidases | 1 | 2020 | 69 | 0.040 |
Why?
| Biological Transport | 1 | 2020 | 164 | 0.040 |
Why?
| Neoplastic Stem Cells | 1 | 2021 | 98 | 0.040 |
Why?
| Radiotherapy | 1 | 2021 | 125 | 0.040 |
Why?
| Heat-Shock Response | 1 | 2020 | 26 | 0.040 |
Why?
| Cytoprotection | 1 | 2019 | 34 | 0.040 |
Why?
| Spheroids, Cellular | 1 | 2019 | 24 | 0.040 |
Why?
| Databases, Genetic | 1 | 2020 | 88 | 0.040 |
Why?
| Poly(A)-Binding Protein I | 1 | 2019 | 5 | 0.040 |
Why?
| Zonula Occludens-1 Protein | 1 | 2019 | 7 | 0.040 |
Why?
| Oogenesis | 1 | 2019 | 15 | 0.040 |
Why?
| Aquaporin 4 | 1 | 2019 | 8 | 0.040 |
Why?
| Polyadenylation | 1 | 2019 | 19 | 0.040 |
Why?
| Crystallins | 1 | 2019 | 11 | 0.040 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2019 | 29 | 0.040 |
Why?
| Eye Proteins | 1 | 2019 | 17 | 0.040 |
Why?
| Chromatography, Gel | 2 | 2010 | 40 | 0.040 |
Why?
| Trihexosylceramides | 1 | 2018 | 3 | 0.040 |
Why?
| Base Sequence | 2 | 2015 | 639 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2019 | 58 | 0.040 |
Why?
| Codon | 1 | 2018 | 44 | 0.040 |
Why?
| Methyltransferases | 1 | 2018 | 30 | 0.040 |
Why?
| Bacteria | 1 | 2020 | 218 | 0.040 |
Why?
| Amino Acid Substitution | 2 | 2008 | 81 | 0.040 |
Why?
| Retinal Pigment Epithelium | 1 | 2018 | 11 | 0.040 |
Why?
| Actin Cytoskeleton | 1 | 2018 | 21 | 0.040 |
Why?
| Autophagy | 1 | 2019 | 170 | 0.040 |
Why?
| beta Catenin | 1 | 2018 | 97 | 0.040 |
Why?
| Transcriptome | 1 | 2020 | 313 | 0.040 |
Why?
| Schizosaccharomyces | 1 | 2018 | 60 | 0.040 |
Why?
| Protein Phosphatase 2 | 1 | 2017 | 4 | 0.040 |
Why?
| Radiation-Protective Agents | 1 | 2018 | 72 | 0.040 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 181 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2018 | 208 | 0.040 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 77 | 0.040 |
Why?
| NFATC Transcription Factors | 1 | 2017 | 23 | 0.040 |
Why?
| Jurkat Cells | 1 | 2017 | 27 | 0.040 |
Why?
| Mice, Inbred CBA | 1 | 2017 | 35 | 0.040 |
Why?
| Hematopoiesis | 1 | 2017 | 72 | 0.030 |
Why?
| Electron Transport Complex III | 1 | 2017 | 6 | 0.030 |
Why?
| Species Specificity | 1 | 2017 | 187 | 0.030 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 22 | 0.030 |
Why?
| Retinoblastoma-Binding Protein 2 | 1 | 2016 | 6 | 0.030 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 24 | 0.030 |
Why?
| Ribonuclease III | 1 | 2016 | 13 | 0.030 |
Why?
| Electron Transport Complex I | 1 | 2017 | 23 | 0.030 |
Why?
| Cyclin D1 | 1 | 2016 | 52 | 0.030 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 11 | 0.030 |
Why?
| Oligopeptides | 1 | 2017 | 95 | 0.030 |
Why?
| Detergents | 1 | 2016 | 14 | 0.030 |
Why?
| Operon | 1 | 2016 | 28 | 0.030 |
Why?
| DEAD-box RNA Helicases | 1 | 2016 | 33 | 0.030 |
Why?
| tau Proteins | 1 | 2016 | 29 | 0.030 |
Why?
| 14-3-3 Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| Azacitidine | 1 | 2016 | 34 | 0.030 |
Why?
| Thiolester Hydrolases | 1 | 2016 | 6 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2017 | 109 | 0.030 |
Why?
| Cyclophilins | 1 | 2016 | 9 | 0.030 |
Why?
| Ubiquitin Thiolesterase | 1 | 2016 | 17 | 0.030 |
Why?
| X Chromosome | 1 | 2016 | 12 | 0.030 |
Why?
| Solubility | 1 | 2016 | 71 | 0.030 |
Why?
| Hydroxylation | 1 | 2016 | 61 | 0.030 |
Why?
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 15 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2016 | 91 | 0.030 |
Why?
| Ubiquitination | 1 | 2016 | 42 | 0.030 |
Why?
| Cosmic Radiation | 1 | 2016 | 34 | 0.030 |
Why?
| Centrifugation | 1 | 2015 | 12 | 0.030 |
Why?
| Osteogenesis Imperfecta | 1 | 2016 | 37 | 0.030 |
Why?
| Endopeptidases | 1 | 2016 | 65 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2016 | 103 | 0.030 |
Why?
| Tissue Distribution | 1 | 2016 | 166 | 0.030 |
Why?
| Protein Interaction Maps | 1 | 2015 | 22 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2015 | 59 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 111 | 0.030 |
Why?
| Cell Death | 1 | 2016 | 175 | 0.030 |
Why?
| Myofibroblasts | 1 | 2016 | 49 | 0.030 |
Why?
| Models, Animal | 1 | 2016 | 227 | 0.030 |
Why?
| Extracellular Matrix | 1 | 2016 | 109 | 0.030 |
Why?
| Reference Values | 1 | 2016 | 307 | 0.030 |
Why?
| Isotope Labeling | 1 | 2015 | 54 | 0.030 |
Why?
| DNA Damage | 1 | 2017 | 301 | 0.030 |
Why?
| Azepines | 1 | 2015 | 19 | 0.030 |
Why?
| Neurodegenerative Diseases | 1 | 2016 | 77 | 0.030 |
Why?
| Gene Expression | 1 | 2017 | 610 | 0.030 |
Why?
| Micronucleus, Germline | 1 | 2014 | 2 | 0.030 |
Why?
| Genotype | 1 | 2016 | 533 | 0.030 |
Why?
| DNA, Protozoan | 1 | 2014 | 12 | 0.030 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2014 | 5 | 0.030 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1000 | 0.030 |
Why?
| Triazoles | 1 | 2015 | 113 | 0.030 |
Why?
| Monoamine Oxidase | 1 | 2014 | 16 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2014 | 64 | 0.030 |
Why?
| Plasmids | 1 | 2014 | 164 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 86 | 0.030 |
Why?
| Antibody Specificity | 1 | 2013 | 35 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 248 | 0.030 |
Why?
| Antibodies | 1 | 2013 | 153 | 0.030 |
Why?
| Chemistry, Pharmaceutical | 1 | 2013 | 33 | 0.030 |
Why?
| Case-Control Studies | 1 | 2016 | 1156 | 0.030 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2012 | 20 | 0.030 |
Why?
| Animals, Outbred Strains | 1 | 2012 | 11 | 0.030 |
Why?
| p300-CBP Transcription Factors | 1 | 2012 | 6 | 0.030 |
Why?
| Thiazoles | 1 | 2013 | 53 | 0.030 |
Why?
| COS Cells | 1 | 2012 | 73 | 0.030 |
Why?
| Sequence Deletion | 1 | 2012 | 67 | 0.030 |
Why?
| Acid Anhydride Hydrolases | 1 | 2012 | 14 | 0.030 |
Why?
| Age Factors | 1 | 2016 | 1110 | 0.030 |
Why?
| Catalytic Domain | 1 | 2012 | 58 | 0.030 |
Why?
| Daptomycin | 1 | 2012 | 29 | 0.030 |
Why?
| Catheter-Related Infections | 1 | 2012 | 48 | 0.020 |
Why?
| Lung | 1 | 2016 | 504 | 0.020 |
Why?
| Bone and Bones | 1 | 2016 | 478 | 0.020 |
Why?
| Drug Design | 1 | 2013 | 119 | 0.020 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2012 | 134 | 0.020 |
Why?
| Arkansas | 1 | 2018 | 1985 | 0.020 |
Why?
| DNA, Neoplasm | 1 | 2012 | 143 | 0.020 |
Why?
| Bacteremia | 1 | 2012 | 89 | 0.020 |
Why?
| Microbial Sensitivity Tests | 1 | 2012 | 269 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 572 | 0.020 |
Why?
| Aged | 2 | 2016 | 9741 | 0.020 |
Why?
| S Phase | 1 | 2010 | 18 | 0.020 |
Why?
| Glycogen Phosphorylase | 1 | 2010 | 2 | 0.020 |
Why?
| Genes, Fungal | 1 | 2010 | 35 | 0.020 |
Why?
| Adenosine Diphosphate | 1 | 2010 | 21 | 0.020 |
Why?
| Oligosaccharides | 1 | 2010 | 34 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3226 | 0.020 |
Why?
| Molecular Conformation | 1 | 2009 | 66 | 0.020 |
Why?
| Rabbits | 1 | 2010 | 372 | 0.020 |
Why?
| RNA, Double-Stranded | 1 | 2008 | 16 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 27 | 0.020 |
Why?
| Tubulin Modulators | 1 | 2008 | 27 | 0.020 |
Why?
| Cohort Studies | 1 | 2013 | 1452 | 0.020 |
Why?
| Vincristine | 1 | 2008 | 82 | 0.020 |
Why?
| Nucleic Acid Denaturation | 1 | 2008 | 14 | 0.020 |
Why?
| Scattering, Radiation | 1 | 2008 | 31 | 0.020 |
Why?
| Cross-Linking Reagents | 1 | 2008 | 41 | 0.020 |
Why?
| Catalysis | 1 | 2008 | 89 | 0.020 |
Why?
| Light | 1 | 2008 | 69 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2013 | 784 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 29 | 0.020 |
Why?
| Photoaffinity Labels | 1 | 2006 | 15 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 745 | 0.020 |
Why?
| Peptide Initiation Factors | 1 | 2006 | 2 | 0.020 |
Why?
| HMGB2 Protein | 1 | 2006 | 2 | 0.020 |
Why?
| Acetyl Coenzyme A | 1 | 2006 | 7 | 0.020 |
Why?
| Antigens, Nuclear | 1 | 2006 | 23 | 0.020 |
Why?
| RNA Polymerase II | 1 | 2006 | 12 | 0.020 |
Why?
| Xenopus | 1 | 2006 | 37 | 0.020 |
Why?
| Enzyme Activation | 1 | 2006 | 268 | 0.020 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2005 | 18 | 0.020 |
Why?
| Microarray Analysis | 1 | 2005 | 70 | 0.020 |
Why?
| Telomere | 1 | 2005 | 35 | 0.020 |
Why?
| Computer Simulation | 1 | 2006 | 279 | 0.020 |
Why?
| Zinc Fingers | 1 | 2005 | 22 | 0.020 |
Why?
| Myeloid-Lymphoid Leukemia Protein | 1 | 2005 | 14 | 0.020 |
Why?
| Multienzyme Complexes | 1 | 2005 | 36 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2005 | 42 | 0.020 |
Why?
| Pregnancy | 1 | 2012 | 2452 | 0.020 |
Why?
| Amino Acids | 1 | 2006 | 373 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2006 | 859 | 0.010 |
Why?
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2003 | 1 | 0.010 |
Why?
| Cyclin B | 1 | 2003 | 4 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 2002 | 33 | 0.010 |
Why?
| Biotinylation | 1 | 2002 | 26 | 0.010 |
Why?
| Biotin | 1 | 2002 | 46 | 0.010 |
Why?
|
|
Tackett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|